CanSino Confirms Immune Response For Coronavirus Vaccine But Safety Concerns Remain

Phase II Results Published

 
• By Brian Yang
  
Vaccination against the new Corona Virus SARS-CoV-2: A syringe being drawn up with SARS-CoV-2 vaccination.
CANSINO PHASE II VACCINE RESULTS SHOW SIGNIFICANT IMMUNE RESPONSE BUT SAFETY CONCERNS REMAIN • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from COVID-19

More from Scrip